Stocktoria

COGNITION THERAPEUTICS INC CGTX

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-10-08

COGNITION THERAPEUTICS INC statistics & valuation

Market cap$100.2M
P / B2.9×
Return on equity-68.5%
Return on capital-138.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-22.90% -53.20% -105.40% -181.20% -68.50% 202020212022202320242025
Shares outstanding
538793 22.2M 29.0M 32.2M 59.9M 88.9M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-110.10% -19.80% -42.40% -73.30% -112.40% -48.50% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$23.76 -$3.13 -$0.91 -$0.86 -$0.86 -$0.32 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-48.5%-112.4%-73.3%-42.4%-19.8%-110.1%
Return on equity-68.5%-181.2%-105.4%-53.2%-22.9%11.5%
Current ratio3.452.653.376.117.502.13

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.